Kwaku Owusu, Co-Founder & CEO
Drugviu is a digital health platform expanding the dataset on health, genomic, and medication outcomes to include Asian, Black, Latino, and Native Americans. These populations are 40% of the U.S. population, but represent less than 6% of participants in clinical trials.
Drugviu has built a safe place for population of color to connect, talk about their health, and share their real-world outcomes including medication efficacy, side effects, and adherence. The company then aggregates their responses by demographics to make it easy for people to discover how medications are performing in other people like them. Along with Drugviu’s website, the company has also partnered with clinics, oncologists, and specialty pharmacies in Ghana, Nigeria, Texas, Illinois, and Hawaii to source medication outcomes across diverse populations. Currently, the company is focused on collecting medication outcomes across cardiovascular conditions, type 2 diabetes, GI, and oncology (breast, lung, prostate, and colorectal cancers). To date, Drugviu has 32,000 medication outcomes—and its growing at 30% per week.
To improve minority representation in clinical trials, Drugviu has built a sophisticated matching algorithm that can identify and place the right patient to the right clinical trial more efficiently. The company sees other applications for its technology including combining its large dataset of therapeutic outcomes with genomic data of underserved populations to help with research and drug design.